Cincinnati

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Melanoma2 trials
• Turner syndrome2 trials
• Cervical cancer1 trial
• Head and neck cancer1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Ovarian cancer1 trial

Phase

• Phase 1/22 trials
• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Ascendis Pharma Oncology Division A/S2 trials
• Ascendis Pharma A/S1 trial
• Ascendis Pharma Endocrinology Division A/S1 trial

Running trials

• Recruiting

  Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

  NCT07221851· Phase 3· Ascendis Pharma A/S· Source

  Contact: Ascendis Registry Inquiries

• Active, not recruiting

  A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

  NCT05690386· Phase 2· Ascendis Pharma Endocrinology Division A/S· Source

• Active, not recruiting

  A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

  NCT05081609· Phase 1/2· Ascendis Pharma Oncology Division A/S· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Turner syndrome1 recruiting

Closed trials

• Terminated

  A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors

  NCT04799054· Phase 1/2· Ascendis Pharma Oncology Division A/S· Source